Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-05-27 13:48 CEST (UTC+2h)
 
VSP
Junior

India,
2017-05-07 21:53

Posting: # 17315
Views: 320
 

 Inclusion of 3 consecutive non-zero conc data with Cmax as a last Con in PK [PK / PD]

Hi All,

I would like to request you please explain the rationale behind the following statement:
Concentration Time profile of a drug must have at least 3 consecutive non-zero concentration data and of which the Cmax must not be the last quantifiable concentration in order to be included in the pharmacokinetic and statistical analyses.

Thanks in advance

VSP
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum | Admin contact
16,926 Posts in 3,626 Threads, 1,030 registered users;
19 users online (0 registered, 19 guests).

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed